Cancer Letters
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 11.8 | Q1 | 91.6% | 3.066 | Q1 | 97.7% |
| 2024 | 10.1 | Q1 | 91.1% | 2.756 | Q1 | 97.3% |
| 2023 | 9.1 | Q1 | 87.7% | 2.595 | Q1 | 97.2% |
| 2022 | 9.7 | Q1 | 86.5% | 2.088 | Q1 | 96.0% |
| 2021 | 9.8 | Q1 | 87.0% | 1.923 | Q1 | 95.6% |
| 2020 | — | — | 2.470 | Q1 | 96.9% | |
| 2019 | — | — | 2.356 | Q1 | 96.7% | |
| 2018 | — | — | 2.240 | Q1 | 96.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-7980
ISSN
0304-3835
country
IEcoverage
1975-2026